Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia
Clinical trial NCT02092324 · COMPLETED
Trial details
- NCT number
- NCT02092324
- Sponsor
- OHSU Knight Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-08
- Primary completion
- 2019-11-22
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.